Please wait
S-3ASR EX-FILING FEES 0001410098 true true false false N/A 0001410098 1 2025-10-07 2025-10-07 0001410098 1 2025-10-07 2025-10-07 0001410098 2 2025-10-07 2025-10-07 0001410098 3 2025-10-07 2025-10-07 0001410098 4 2025-10-07 2025-10-07 0001410098 2025-10-07 2025-10-07 iso4217:USD xbrli:pure xbrli:shares

Ex-Filing Fees

CALCULATION OF FILING FEE TABLES

S-3

CorMedix Inc.

Table 1: Newly Registered and Carry Forward Securities

                                           
Line Item Type   Security Type   Security Class Title   Notes   Fee Calculation
Rule		   Amount Registered   Proposed Maximum Offering
Price Per Unit		   Maximum Aggregate Offering Price   Fee Rate   Amount of Registration Fee
                                           
Newly Registered Securities
Fees to be Paid   Equity   Common Stock, $0.001 par value per share   (1)   457(o)   6,323,833   $ 11.07   $ 70,004,831.31   0.0001381   $ 9,667.67
                                           
Total Offering Amounts:   $ 70,004,831.31         9,667.67
Total Fees Previously Paid:               0.00
Total Fee Offsets:               9,667.67
Net Fee Due:             $ 0.00

 

__________________________________________
Offering Note(s)

(1) Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), the shares being registered hereunder include such indeterminate number of shares of common stock as may be issuable with respect to the shares being registered hereunder as a result of stock splits, stock dividends or similar transactions.

Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(c) under the Securities Act. The proposed maximum offering price per share and proposed maximum aggregate offering price are based on the average of the high and low prices of the CorMedix Inc.’s (the “Company”) common stock on October 2, 2025 as reported on the Nasdaq Global Market.

Represents shares of the Company’s common stock that may be offered and sold from time to time by the selling securityholders identified herein and includes: (i) 3,323,833 shares of common stock issued to the selling securityholders pursuant to that certain Agreement and Plan of Merger, dated as of August 7, 2025, by and among the Company, Melinta Therapeutics, LLC, a Delaware limited liability company (“Melinta”), Coriander BidCo LLC, a Delaware limited liability company and a wholly owned subsidiary of the Company, and Deerfield Private Design Fund IV, L.P., a Delaware limited partnership (“Deerfield IV”), solely in its capacity as representative, agent and attorney-in-fact of the Melinta equityholders (the “Members’ Representative”) and (ii) up to 3,000,000 shares of common stock (“Milestone Shares”) that may be issuable upon the achievement of certain milestones as set forth in that certain Contingent Payment Agreement, dated as of August 29, 2025, by and among the Company, Melinta, Deerfield IV, Deerfield Private Design Fund III, L.P., a Delaware limited partnership, and the Members’ Representative, based upon certain assumptions as to the maximum number of shares issuable as Milestone Shares.

Table 2: Fee Offset Claims and Sources

                                                         
Line Item Type   Registrant or Filer Name   Notes   Form or Filing Type   File Number   Initial Filing Date   Filing Date   Fee Offset Claimed   Security Type Associated with Fee Offset Claimed   Security Title Associated with Fee Offset Claimed   Unsold Securities Associated with Fee Offset Claimed   Unsold Aggregate Offering Amount Associated with Fee Offset Claimed   Fee Paid with Fee Offset Source
                                                         
Rule 457(p)
Fee Offset Claims   CorMedix Inc.    (1)   S-3   333-290721   10/06/2025       $ 9,667.67   Equity   Common Stock, $0.001 par value per share     6,323,833   $ 70,004,831.31   $  
Fee Offset Claims   CorMedix Inc    (2)   S-3   333-290636   09/30/2025         0.00   Equity   Common Stock, $0.001 par value per share     6,323,833     70,637,214.60      
Fee Offset Sources   CorMedix Inc.        S-3   333-290721       10/06/2025                               0.00
Fee Offset Sources   CorMedix Inc        S-3   333-290636       09/30/2025                               10,814.56
                                                         

__________________________________________
Rule 457(p) Statement of Withdrawal, Termination, or Completion:

(1) A filing fee of $9,755.00 was previously paid in connection with the Registration Statement on Form S-3ASR (No. 333-290721) (the “October Registration Statement”) filed by the registrant on October 6, 2025. The registrant withdrew the October Registration Statement by filing a Form RW on October 7, 2025. No securities were sold under the October Registration Statement. In accordance with Rule 457(p) of the Securities Act, such previously paid filing fee will offset the filing fee payable in connection with this filing.

Rule 457(p) Statement of Withdrawal, Termination, or Completion:

(2) A filing fee of $10,814.56 was previously paid in connection with the Registration Statement on Form S-3 (No. 333-290636) (the “September Registration Statement”) filed by the registrant on September 30, 2025. The registrant withdrew the September Registration Statement by filing a Form RW on October 3, 2025. As the September Registration Statement was not declared effective, no securities were sold thereunder. In accordance with Rule 457(p) of the Securities Act, such previously paid filing fee will offset the filing fee payable in connection with this filing.